Tezespir subcutaneous injection 210mg pen (YJ code: 2290403G2021, standard: 210mg 1.91mL x 1 kit) is an AstraZeneca medication containing Tezpelumab (genetical recombination). The pre-filled pen is used for subcutaneous injection, typically administered once every 4 weeks in adults and children over 12 years old.
Tezespir subcutaneous injection 210mg pen
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).